Ras- and mitogen-activated protein kinase kinase-dependent and - independent pathways in p21(Cip2/Waf1) induction by fibroblast growth factor- 2, platelet-derived growth factor, and transforming growth factor-β1

Cell Growth and Differentiation

Volumn 10, Issue 9, 1999, Pages 621-628

  Kivinen, Laura ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR B; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; GROWTH REGULATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH SUBSTANCES; KINETICS; MAP KINASE KINASE 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; RAS PROTEINS; RNA, MESSENGER; S PHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0032880860     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Marshall, C. J. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
2. Satoh, T., Nakafuku, M., and Kaziro, Y. Function of Ras as a molecular switch in signal transduction. J. Biol. Chem., 267: 24149-24152, 1992.
3. Mulcahy, L. S., Smith, M. R., and Stacey, D. W. Requirement for Ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (Lond.), 313: 241-243, 1985.
4. Stacey, D. W., Roudebush, M., Day, R., Mosser, S. D., Gibbs, J. B., and Feig, L. A. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene, 6: 2297-2304, 1991.
5. Chao, M. V. Growth factor signaling: where is the specificity? Cell, 68: 995-997, 1992.
6. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88: 593-602, 1997.
7. Pages, G., Lenormand, P., L'Allemain, G., Chambard, J-C., Meloche, S., and Pouyssegur, J. Mitogen-activated protein kinase p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA, 90: 8319-8323, 1993.
8. Hunter, T. Oncoprotein networks. Cell, 88: 333-346, 1997.
9. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell, 77: 841-852, 1994.
10. Thomas, S. M., DeMarco, M., D'Arcangelo, G., Halegoua, S., and Brugge, J. S. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell, 68: 1031-1040, 1992.
11. Wood, K. W., Samecki, C., Roberts, T. M., and Blenis, J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1 and RSK. Cell, 68: 1041-1050, 1992.
12. Gardner, A. M., and Johnson, G. L. Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires ras and the activation of mitogen-activated protein kinase. J. Biol. Chem., 271: 14560-14566, 1996.
13. de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Marshall, C. J., and Bos, J. L. Involvement of p21 ras in activation of extracellular signal-regulated kinase 2. Nature (Lond.), 357: 602-604, 1992.
14. Burgering, B. M. T., de Vries-Smits, A. M. M., Medema, R. H., van Weeren, P. C., Tertoolen, L. G. J., and Bos, J. L. Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol. Cell. Biol., 13: 7248-7256, 1993.
15. Hartsough, M. T., Frey, R. S., Zipfel, P. A., Buard, A., Cook, S. J., McCormick, F., and Mulder, K. M. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J. Biol. Chem., 271: 22368-22375, 1996.
16. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol., 16: 3923-3933, 1996.
17. Urano, T., Emkey, R., and Feig, L. A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J., 15: 810-816, 1996.
18. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M., Waterfield, M. D., and Downward, J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (Lond.), 370: 527-532, 1994.
19. Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., and Der, C. J. Increasing complexity of Ras signaling. Oncogene, 17: 1395-1413, 1998.
20. Hawes, B. E., van Biesen, T., Koch, W. J., Luttrell, L. M., and Lefkowitz, R. J. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem., 270: 17148-17153, 1995.
21. Ueda, Y., Hirai, S-I., Osada, S-I., Suzuki, A., Mizuno, K., and Ohno, S. Protein kinase C delta activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem., 271; 23512-23519, 1996.
22. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
23. Parker, S. B., Elchele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., and Elledge, S. J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
24. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
25. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
26. Cheng, M., Olivier, P., Diehl, J. A., Fera, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J. The p21Cip1 and p27Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 18: 1571-1583, 1999.
27. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
28. Yan, G-Z., and Ziff, E. B. Nerve growth factor induces transcription of the p21WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci., 17: 6122-6132, 1997.
29. Pumiglia, K. M., and Decker, S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA, 94: 448-452, 1997.
30. Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., and Mendelsohn, J. Prolonged induction of p21Cip1/Waf1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell Biol., 131: 235-242, 1995.
31. Datto, M. B., Yu, Y., and Wang, X-F. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem., 270: 28623-28628, 1995.
32. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
33. Johnson, M. R., Valentine, C., Basilico, C., and Mansukhani, A. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene, 16: 2647-2656, 1998.
34. Zezula, J., Sexl, V., Hutter, C., Karel, A., Schütz, W., and Freissmuth, M. The cyclin-dependent kinase inhibitor p21Cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J. Biol. Chem., 272: 29967-29974, 1997.
35. Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M. B., Wang, X-F., and Laiho, M. Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites. Oncogene, in press, 1999.
36. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf-activity with arrest mediated by p21Cip1. Mol. Cell. Biol., 17: 5598-5611, 1997.
37. Sewing, A., Wiseman, B., Lloyd, A., and Land, H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol., 17: 5588-5597, 1997.
38. Liu, Y., Martindale, J. L., Gorospe, M., and Holbrook, N. J. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res., 56: 31-35, 1996.
39. Olson, M. F., Paterson, H. F., and Marshall, C. J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature (Lond.), 394: 295-299, 1998.
40. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massagué, J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
41. Yue, J., Buard, A., and Mulder, K. M. Blockade in TGF β 3 upregulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells. Oncogene, 17: 47-55, 1998.
42. Schweppe, R. E., Frazer-Abel, A. A., Gutierrez-Hartmann, A., and Bradford, A. P. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. J. Biol. Chem., 272: 30852-30859, 1997.
43. Tan, Y., Rouse, J., Zhang, A., Cariati, S., Cohen, P., and Comb, M. J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J., 15: 4629-4642, 1996.
44. Lubinus, M., Meier, K. E., Smith, E. A., Gause, K. C., LeRoy, E. C., and Trojanowska, M. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J. Biol. Chem., 269: 9822-9825, 1994.
45. Reynisdottir, I., Polyak, K., lavarone, A., and Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
46. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
47. Reimann, T., Hempel, U., Krautwald, S., Axmann, A., Scheibe, R., Seidel, D., and Wenzel, K-W. Transforming growth factor-β induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett., 403: 57-60, 1997.
48. Chatani, Y., Tanimura, S., Miyoshi, N., Hattori, A., Sato, M., and Kohno, M. Cell type-specific modulation of cell growth by transforming growth factor β1 does not correlate with mitogen-activated protein kinase activation. J. Biol. Chem., 270: 30686-30692, 1995.
49. Mulder, K. M., and Morris, S. L. Activation of p21 ras by transforming growth factor β in epithelial cells. J. Biol. Chem., 267: 5029-5031, 1992.
50. Hartsough, M. T., and Mulder, K. M. Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells. J. Biol. Chem., 270: 7117-7124, 1995.
51. Gorospe, M., Wang, X., and Holbrook, N. J. p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol. Cell. Biol., 18: 1400-1407, 1998.
52. Kivinen, L., Tiihonen, E., Haapajärvi, T., and Laiho, M. p21ras-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms. Cell Growth Differ., 7: 1705-1712, 1996.
53. Kivinen, L., Pitkänen, K., and Laiho, M. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts. Oncogene, 8: 2703-2711, 1993.
54. Haapajärvi, T., Kivinen, L., Pitkänen, K., and Laiho, M. Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene, 11: 151-159, 1995.